Ballyk BA - Search Results

1

4-Alkylidenyl glutamic acids, potent and selective GluR5 agonists.

Baker SR, Bleakman D, Ezquerra J, Ballyk BA, Deverill M, Ho K, Kamboj RK, Collado I, Domínguez C, Escribano A, Mateo AI, Pedregal C, Rubio A. Baker SR, et al. Among authors: ballyk ba. Bioorg Med Chem Lett. 2000 Aug 21;10(16):1807-10. doi: 10.1016/s0960-894x(00)00346-2. Bioorg Med Chem Lett. 2000. PMID: 10969973

2

4-Alkyl- and 4-cinnamylglutamic acid analogues are potent GluR5 kainate receptor agonists.

Pedregal C, Collado I, Escribano A, Ezquerra J, Domínguez C, Mateo AI, Rubio A, Baker SR, Goldsworthy J, Kamboj RK, Ballyk BA, Hoo K, Bleakman D. Pedregal C, et al. Among authors: ballyk ba. J Med Chem. 2000 May 18;43(10):1958-68. doi: 10.1021/jm9911682. J Med Chem. 2000. PMID: 10821708

3

LY339434, a GluR5 kainate receptor agonist.

Small B, Thomas J, Kemp M, Hoo K, Ballyk B, Deverill M, Ogden AM, Rubio A, Pedregal C, Bleakman D. Small B, et al. Neuropharmacology. 1998 Oct-Nov;37(10-11):1261-7. doi: 10.1016/s0028-3908(98)00122-1. Neuropharmacology. 1998. PMID: 9849663

4

Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles.

Bleakman D, Ballyk BA, Schoepp DD, Palmer AJ, Bath CP, Sharpe EF, Woolley ML, Bufton HR, Kamboj RK, Tarnawa I, Lodge D. Bleakman D, et al. Among authors: ballyk ba. Neuropharmacology. 1996;35(12):1689-702. doi: 10.1016/s0028-3908(96)00156-6. Neuropharmacology. 1996. PMID: 9076748

5

A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission.

Clarke VR, Ballyk BA, Hoo KH, Mandelzys A, Pellizzari A, Bath CP, Thomas J, Sharpe EF, Davies CH, Ornstein PL, Schoepp DD, Kamboj RK, Collingridge GL, Lodge D, Bleakman D. Clarke VR, et al. Among authors: ballyk ba. Nature. 1997 Oct 9;389(6651):599-603. doi: 10.1038/39315. Nature. 1997. PMID: 9335499

6

Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.

Bleakman R, Schoepp DD, Ballyk B, Bufton H, Sharpe EF, Thomas K, Ornstein PL, Kamboj RK. Bleakman R, et al. Mol Pharmacol. 1996 Apr;49(4):581-5. Mol Pharmacol. 1996. PMID: 8609884

7

Osmotic effects on the CA1 neuronal population in hippocampal slices with special reference to glucose.

Ballyk BA, Quackenbush SJ, Andrew RD. Ballyk BA, et al. J Neurophysiol. 1991 May;65(5):1055-66. doi: 10.1152/jn.1991.65.5.1055. J Neurophysiol. 1991. PMID: 1651372

8

Seizure susceptibility and the osmotic state.

Andrew RD, Fagan M, Ballyk BA, Rosen AS. Andrew RD, et al. Among authors: ballyk ba. Brain Res. 1989 Sep 25;498(1):175-80. doi: 10.1016/0006-8993(89)90417-4. Brain Res. 1989. PMID: 2790471

9

Elevation of extracellular potassium facilitates the induction of hippocampal long-term potentiation.

Ballyk BA, Goh JW. Ballyk BA, et al. J Neurosci Res. 1992 Dec;33(4):598-604. doi: 10.1002/jnr.490330412. J Neurosci Res. 1992. PMID: 1484393

10

A postsynaptic G-protein in hippocampal long-term potentiation.

Ballyk BA, Goh JW. Ballyk BA, et al. Brain Res. 1993 May 14;611(1):81-6. doi: 10.1016/0006-8993(93)91780-v. Brain Res. 1993. PMID: 8390912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page